ACAD - Acadia Pharmaceuticals Inc
IEX Last Trade
16.59
0.270 1.627%
Share volume: 907,400
Last Updated: Fri 30 Aug 2024 09:59:56 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$16.32
0.27
1.65%
Summary score
23%
Profitability
24%
Dept financing
10%
Liquidity
49%
Performance
20%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-7.79%
Return on assets
-5.97%
Return on sales
-33.84%
Return on invested capital
133.92%
Total debt ratio
29.39%
Debt ratio change over timeo
-1.93%
Current Ratio
4.95%
Quick Ratio
4.86%
Cash Position Ratio
3.9%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-0.88%
Return on assets
-0.55%
Return on sales
-0.73%
Return on invested capital
8.46%
Total debt ratio
42.31%
Debt ratio change over timeo
-5.4%
Current Ratio
2.37%
Quick Ratio
2.25%
Cash Position Ratio
1.7%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
3.57%
Return on assets
1.78%
Return on sales
7.39%
Return on invested capital
-10.98%
Total debt ratio
45.73%
Debt ratio change over time
-2.21%
Current Ratio
2.04%
Quick Ratio
1.86%
Cash Position Ratio
1.42%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-114.77%
Return on assets
-109.44%
Return on sales
-143.18%
Return on invested capital
31.69%
Total debt ratio
-192.67%
Debt ratio change over time
-1.93%
Current Ratio
-4.55%
Quick Ratio
-4.39%
Cash Position Ratio
-3.51%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ACAD | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -7.79% | 13.79% | 34.47% | 7.43% |
| Return on assets | -5.97% | 2.76% | 3.15% | 5.62% |
| Return on sales | -33.84% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 133.92% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 40% | 60% | 59% |
| Total debt ratio | 29.39% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.93% | 308.97% | -6.99% | 1.18% |
| Dept financing | 8% | 50% | 25% | 7% |
| Current Ratio | 2.37% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 2.25% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 1.7% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 11% | 24% | 55% |
| Short-term ratios | ACAD | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -0.88% | 13.77% | 13.25% | 3.8% |
| Return on assets | -0.55% | 2.43% | 1.89% | 3.09% |
| Return on sales | -0.73% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 8.46% | 2.14% | 3.39% | 9.18% |
| Profitability | 23% | 71% | 68% | 82% |
| Total debt ratio | 42.31% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -5.4% | 46.38% | -72.08% | 1.51% |
| Dept financing | 11% | 50% | 25% | 7% |
| Current Ratio | 2.37% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 2.25% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 1.7% | 0.36% | 1.28% | 2.93% |
| Liquididy | 38% | 12% | 31% | 75% |